» Articles » PMID: 27412110

Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: From History to the Interaction with the Monoaminergic Systems

Overview
Journal Prog Neurobiol
Specialty Neurology
Date 2016 Jul 15
PMID 27412110
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease is the second most common neurodegenerative disorder, characterized by the manifestation of motor symptoms, which are mainly attributed to the degeneration of dopamine neurons in the pars compacta of substantia nigra. Based on advancements in the understanding of the pathophysiology of the disease, especially in animal models, the subthalamic nucleus has been pointed as a major target for deep brain stimulation in the treatment of motor symptoms, first developed in non-human primate and then successfully transfered to parkinsonian patients. Nevertheless, despite the focus on motor deficits, Parkinson's disease is also characterized by the manifestation of non-motor symptoms, which can be due to the additional degeneration of norepinephrine, serotonin and cholinergic systems. The pathophysiology of the non-motor symptoms is under studied and consequently not well treated. Furthermore, data from the literature about the impact of subthalamic deep brain stimulation on non-motor disorders are controversial and still under debate. Similarly, the risk of mood disorders post-deep brain stimulation surgery remains also controversial. Here, we review the clinical and experimental data of this neurosurgical approach on motor and non-motor behaviors and provide evidence for its interaction with the monoaminergic systems.

Citing Articles

Deep Brain Stimulation Lead Functional Repositioning After Spontaneous Pneumocephalus Resorption: A Clinical Case Presentation and Systematic Review.

Lebron Sanchez Y, Torres V, Carreras A, Jimenez Marrero A, Bleubar Ozoria R, Rivera L Cureus. 2025; 17(1):e77506.

PMID: 39958129 PMC: 11828712. DOI: 10.7759/cureus.77506.


Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.

Cui X, Li X, Zheng H, Su Y, Zhang S, Li M NPJ Parkinsons Dis. 2024; 10(1):189.

PMID: 39428415 PMC: 11491477. DOI: 10.1038/s41531-024-00799-8.


Effects of non-invasive brain stimulation on walking and balance ability in Parkinson's patients: A systematic review and meta-analysis.

Zhang X, Jing F, Liu Y, Tang J, Hua X, Zhu J Front Aging Neurosci. 2023; 14:1065126.

PMID: 36704502 PMC: 9871558. DOI: 10.3389/fnagi.2022.1065126.


A nigro-subthalamo-parabrachial pathway modulates pain-like behaviors.

Jia T, Wang Y, Chen J, Zhang X, Cao J, Xiao C Nat Commun. 2022; 13(1):7756.

PMID: 36522327 PMC: 9755217. DOI: 10.1038/s41467-022-35474-0.


Differential modulation of subthalamic projection neurons by short-term and long-term electrical stimulation in physiological and parkinsonian conditions.

Xiao C, Ji Y, Luan Y, Jia T, Yin C, Zhou C Acta Pharmacol Sin. 2021; 43(8):1928-1939.

PMID: 34880404 PMC: 9343451. DOI: 10.1038/s41401-021-00811-4.